Soleno Therapeutics [SLNO] vs Blueprint Medicines [BPMC] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 12 vital metrics comparison: Soleno Therapeutics wins in 6 metrics, Blueprint Medicines wins in 4 metrics, with 1 ties. Soleno Therapeutics appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Soleno Therapeutics Blueprint Medicines Better
P/E Ratio (TTM) N/A -119.59 N/A
Price-to-Book Ratio 16.54 24.15 Soleno Therapeutics
Debt-to-Equity Ratio 22.73 208.50 Soleno Therapeutics
PEG Ratio -34.87 -136.13 Blueprint Medicines
EV/EBITDA -18.56 -53.15 Blueprint Medicines
Profit Margin 0.00% -27.70% Soleno Therapeutics
Operating Margin 0.00% -27.50% Soleno Therapeutics
Return on Equity -105.54% -47.71% Blueprint Medicines
Return on Assets -52.40% -9.75% Blueprint Medicines
Free Cash Flow $-69.31M $-197.22M Soleno Therapeutics
Dividend Yield 0.00% 0.00% Tie
1-Year Return 86.63% 21.23% Soleno Therapeutics
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Soleno Therapeutics vs Blueprint Medicines Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Soleno Therapeutics vs Blueprint Medicines Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...